How Menopause Accelerates Collagen Loss and Structural Skin Ageing

Menopause induces a hormonally mediated remodelling of the dermis.

Within the first five years following menopause, women lose approximately 30% of dermal collagen, with continued annual decline thereafter [1].

Oestrogen withdrawal impacts:

• Collagen I and III synthesis
• Dermal thickness
• Elastic fibre organisation
• Endogenous hyaluronic acid levels
• Transepidermal water loss (TEWL)

Histological studies confirm measurable dermal thinning associated with menopause [1].

Clinically, this presents as:

• Loss of firmness
• Wrinkle formation
• Reduced elasticity
• Skin dryness
• Structural support decline

Menopausal skin should therefore be approached as hormone-driven structural ageing, not simply chronological skin ageing.

Recent discussions at IMCAS World Congress further highlighted the prevalence and psychosocial impact of menopause-related skin deterioration [2][3].

Why Menopausal Skin Requires a Layered Aesthetic Treatment Protocol

Isolated volumisation does not address extracellular matrix degradation.

An effective menopause aesthetic protocol should target:

1. Collagen depletion
2. Hyaluronic acid reduction
3. Cellular regenerative slowdown
4. Fat compartment redistribution

This layered strategy aligns with regenerative and longevity-oriented aesthetic medicine.

4-Layer Clinical Protocol for Menopausal Skin Rejuvenation

Layer 1: Collagen Biostimulation for Menopausal Dermal Matrix Restoration

Objective: Reactivate fibroblast activity and stimulate collagen I & III synthesis.

Collagen depletion during early menopause is quantitatively significant and clinically relevant [1].

Available CE-marked options at Fräya:

• Sculptra 
• Radiesse
• Ellansé
• Profhilo H+L

Collagen biostimulation addresses the underlying dermal deficit and is typically foundational within menopause treatment plans.

Layer 2: Skin Boosters and Dermal Hydration for Post-Menopausal TEWL and HA Loss

Objective: Restore hyaluronic acid density and improve dermal hydration.

Oestrogen decline contributes to reduced HA synthesis and increased TEWL [1], providing clinical rationale for targeted hydration protocols.

Available at Fräya:

• Jalupro Super Hydro
• Restylane Skinboosters
• Viscoderm Hydrobooster
• Refine+ Ultra Soft

Hydration protocols support elasticity, luminosity and dermal microarchitecture.

Layer 3: Polynucleotides for Cellular Regeneration in Menopausal Skin

Objective: Support fibroblast proliferation, ECM repair and oxidative stress modulation.

Emerging clinical evidence suggests polynucleotides may contribute to dermal regeneration and structural repair pathways [3].

• Nucleofill
• Plinest
• Croma PolyPhil

These treatments act at a cellular signalling level rather than providing volumetric correction.

Layer 4: Structural Dermal Fillers for Volume Redistribution After Menopause

Objective: Address fat compartment deflation and ligament laxity secondary to collagen decline.

Structural HA fillers available at Fräya:

• Juvéderm Voluma
• Restylane Lyft
• Belotero Volume

Volume restoration should follow dermal matrix stabilisation rather than compensate for its absence.

Clinical Sequencing for Menopausal Skin Rejuvenation

Month 0–1

Collagen biostimulation ± polynucleotides

Month 1–2

Skin booster protocol

Month 2–3

Selective structural HA correction

Maintenance

Annual collagen support and hydration reinforcement

This sequencing reflects biological layering rather than aesthetic layering.

FAQ: Menopause and Aesthetic Treatment Strategies

How does menopause affect collagen production?

Oestrogen decline reduces fibroblast stimulation, leading to accelerated collagen loss — particularly in the first five years post-menopause [1].

What is the best treatment for menopausal skin?

Evidence supports a layered approach combining biostimulation, hydration and regenerative strategies aligned with dermal pathophysiology.

Are skin boosters effective for menopausal skin?

Yes. Increased TEWL and reduced endogenous HA provide clinical rationale for targeted hydration protocols [1].

Should dermal fillers be used first?

In menopause-related skin decline, matrix stabilisation is generally recommended prior to volumisation.

Conclusion: Structured Treatment for Hormone-Driven Collagen Loss

Menopause-associated collagen loss is hormonally driven, histologically documented and clinically significant [1].

A structured menopause skin treatment protocol incorporating:

• Collagen biostimulation
• Skin boosters
• Polynucleotide regeneration
• Structural fillers

aligns with contemporary regenerative aesthetic medicine and long-term patient management.

All referenced products are available at frayamedsupply.com, selected for CE-marked regulatory compliance and professional clinical use.

References

[1] Brincat M. et al. British Journal of Obstetrics and Gynaecology. 1987;94(2):126–129. (PubMed 3120067)

[2] Data presented at IMCAS World Congress 2025

[3] Fabi SG et al. Poster presentation, IMCAS 2025